OraSure to Present at J.P Morgan Healthcare Conference

BioUtah to Attend the J.P. Morgan 43rd Annual Healthcare Conference
BioUtah, the trade association, common voice, and flag bearer for Utah's life sciences industry, today announced that it will participate in the J.P. Morgan 43rd Annual Healthcare Conference, January 12-16,
Samsung, Celltrion to exhibit at J.P. Morgan Healthcare Conference
Korean biopharmaceutical firms Samsung Biologics, Celltrion, and Lotte Biologics will showcase their advancements at the J.P. Morgan Healthcare Conference.
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website here.
Celltrion to reveal four-year road map at J.P. Morgan Healthcare Conference
Celltrion will reveal its dual-track strategy to juggle the development of both biosimilars and original drugs at the J.P. Morgan Healthcare Conference.
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2025 J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 4:30 p.m. PST. A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations .
Waystar to Present at J.P. Morgan Healthcare Conference
Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Monday,
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
To access the live webcast or subsequent archived recording of the company presentation, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.
J.P. Morgan increases security for 2025 conference
The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health and pharmaceutical sectors.
DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference
BALTIMORE and PALO ALTO, Calif., Jan. 8, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, today announced the company will participate in the upcoming 43 rd Annual J.P. Morgan Healthcare Conference in San Francisco.
Nvidia In Focus: CES This Week, J.P. Morgan Healthcare Conference Next Week, February Earnings
Then, next week, Nvidia is on the road again at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, which ...
Business Wire3d
Ensem Therapeutics Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Ensem Therapeutics, Inc. (ENSEM), a pioneering drug discovery and development company that leverages its unique Kinetic ...
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
LOS GATOS, CA / ACCESSWIRE / / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for ...